Top Articles
#1 in Business Subscribe Email Print

You are here: Home > Finance > Investing > My Favorite Ways to Invest in Asia

Tags

  • there
  • youve
  • companies involved
  • developing combination
  • developing combination

  • Links

  • Instant Willpower
  • What Is A 401k Plan?
  • The Dangers Of Childhood Obesity
  • Top Articles - My Favorite Ways to Invest in Asia

    Meanwhile, Asian economies show no sign of slowing down. And that’s why I advocate paying attention both to the companies that are based there and the American companies that are doing business there ... the right way. More on that in a moment.

    First, I want to tell you about ...

    Three Asian Industries That Look Absolutely Unstoppable!

    As an investor, you get to put your money to w
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    ork in practically any kind of business imaginable. So, here’s an important question: What kind of businesses in Asia look poised to grow? My answers ...

    Construction: You need look no further than China to understand why this industry has such great prospects. The country is throwing up giant skyscrapers ... paving new roads ... and building new power plants.

    Maybe you think it’s to
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    late to get in? Well, if anything, I think activity will pick up — not slow down — as the 2008 Olympics approach. We still have another year or two left in this cycle, and that’s plenty of time for some of these stocks to double.

    Cargo and Containers: One trip to Wal-Mart will prove that China has become the world’s manufacturing center. Today, just about everything on store shelves
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    as made in China (or some other Asian country).

    But it’s hard to consistently figure out who will make the next hot product. That’s why I like companies involved in transporting goods from factory floors to store shelves.

    Investors have tons of choices here. They can buy shares of companies that run China’s toll roads. They can put their money into railroad companies. And they can al
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    o consider port operators, since almost every item eventually boards a ship.

    Of course, I do like some manufacturers and retailers. Particularly the ones that cater to ...

    Chuppies: Asia is all about consumption. Every time I visit, I’m bowled over by the sheer volume of shopping going on. I’m not talking about people buying crappy t-shirts, either.

    Instead, Chinese yuppies (I call
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    hem “Chuppies”) are greedily snapping up cell phones ... staying at lavish hotels ... gambling at casinos ... and sporting expensive jewelry.

    At this point, you might be thinking that U.S. companies should be making a killing off of this new market. Well, some are. But others are coming up short. Here’s why ...

    Some American Companies Just Don’t Get Asian Markets

    Take restaurants —
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    like their U.S. counterparts, Asians love dining out. However, many U.S. restaurants have found it difficult to operate in places like China.

    One major problem is adapting a menu to the very localized Asian taste buds. Heck, you won’t find pigeon, duck tongue, or dog on a Burger King menu in the U.S., will you?

    It’s also hard to adapt to a completely different culture in other ways.
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    Advertisements that would be harmless in America can tick off the entire population of another country. For example, Nike ran a TV spot that showed NBA superstar LeBron James playing and defeating a computer-generated Kung-Fu master. People were so insulted that the Chinese government banned the ad.

    And I haven’t even gotten to the business environment, which can be downright cut-thro
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    t! Look at what happened to Best Buy when it tried to open its first Chinese store:

    The company was going to take over a prime Beijing commercial space that was vacated by Ikea ... until Gome, a Chinese retailer, heard about it. To add insult to injury, Gome leased the place for $2.5 million a year even though Best Buy had been offering four times as much. Preferential treatment for a
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    local firm? You be the judge.

    My point is that succeeding in Asia is a lot more complicated than opening an office or hanging up a shingle. As an investor, you can’t assume that every company with a strategy for China will succeed. And you’ve got to be especially careful when you’re getting your stake in Asia through your U.S. holdings.

    Don’t worry, though ...

    There Are Five Easy
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    ays to Invest in Asia

    I want to make something clear — I’m not suggesting that you abandon all of your U.S. holdings, even the ones with absolutely zero exposure to Asia.

    However, I do think it’s foolish to have your portfolio entirely invested in any one country, especially if it’s the slow-growing U.S. There’s no excuse for that nowadays. Not when you have so many ways to invest ab
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    road. Here are just five of the ways to invest in Asia:

    First, you can buy a mutual fund that’s focused on either one or more Asian countries. Three I like are U.S. Global’s China Region Opportunity (USCOX), Fidelity’s China Region (FHKCX), and T. Rowe Price’s New Asia (PRASX).

    Second, consider exchange-traded funds. These investments give you a diversified stake in specific regions,
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    they’re easily bought and sold, and they generally carry lower fees than mutual funds.

    Third, you can buy shares of Asian companies that trade on American exchanges. Many come in the form of American Depositary Receipts (ADRs), which are U.S.-listed stocks that trade exactly like their foreign-listed counterparts.

    Fourth, if your broker has a foreign trading desk, you can buy shares
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    f Asian companies that are listed on foreign exchanges. This isn’t nearly as hard as many people think. A lot of the most attractive Chinese companies are listed on the Hong Kong Stock Exchange, but some can also be found on exchanges in Singapore, London, Shenzhen, and Shanghai.

    Fifth, there are some American companies that are getting it right overseas. You’ve got to choose carefull
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    , but U.S. firms with strong presences in Asia are one last familiar way for you to get a stake in economies that are absolutely trouncing the paltry growth happening on American soil.

    Best wishes,

    Tony

    P.S. If you want someone to help you find the best Asian investments, consider subscribing to my Asia Stock Alert service.

    About MONEY AND MARKETS

    For more information and archived
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    issues, visit http://www.moneyandmarkets.com

    MONEY AND MARKETS (MaM) is published by Weiss Research, Inc. and written by Martin D. Weiss along with Sean Brodrick, Larry Edelson, Michael Larson, Nilus Mattive, and Tony Sagami. To avoid conflicts of interest, Weiss Research and its staff do not hold positions in companies recommended in MaM. Nor do we accept any compensation for such re
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    commendations. The comments, graphs, forecasts, and indices published in MaM are based upon data whose accuracy is deemed reliable but not guaranteed. Performance returns cited are derived from our best estimates but must be considered hypothetical inasmuch as we do not track the actual prices investors pay or receive. Regular contributors and staff include John Burke, Amber Dakar, Wen
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    y Montes de Oca, Kristen Adams, Jennifer Moran, Red Morgan, and Julie Trudeau.

    Attention editors and publishers! Money and Markets issues can be republished. Republished issues MUST include attribution of the author(s) and the following short paragraph:

    This investment news is brought to you by Money and Markets. Money and Markets is a free daily investment newsletter from Martin D.
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    eiss and Weiss Research analysts offering the latest investing news and financial insights for the stock market, including tips and advice on investing in gold, energy and oil. Dr. Weiss is a leader in the fields of investing, interest rates, financial safety and economic forecasting. To view archives or subscribe, visit http://www.MoneyandMarkets.com

    From time to time, Money and Mark
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    ts may have information from select third-party advertisers known as "external sponsorships." We cannot guarantee the accuracy of these ads. In addition, these ads do not necessarily express the viewpoints of Money and Markets or its editors. For more information, see our terms and conditions.

    © 2007 by Weiss Research, Inc. All rights reserved. 15430 Endeavour Drive, Jupiter, FL 3347


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.toparticles.org.ua/article/102372/toparticles-My-Favorite-Ways-to-Invest-in-Asia.html">My Favorite Ways to Invest in Asia</a>

    BB link (for phorums):
    [url=http://www.toparticles.org.ua/article/102372/toparticles-My-Favorite-Ways-to-Invest-in-Asia.html]My Favorite Ways to Invest in Asia[/url]

    Related Articles:

    Work From Home

    Debt Consolidation For More Young Adults – Why Is That So?

    The Key to Building Wealth

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com